Gao Hanlin → Fulgent Genetics, Inc. FLGT

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 11.43

2,753,798 shares short · +4.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $6.22M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-05-26	Hsieh Ming	director, officer, 10%+ owner	F	2,949	$17.67	$52K

Other 13D/G Filings on Fulgent Genetics, Inc.

Filed	Form	Filer	Stake	Shares
2026-05-27	SCHEDULE 13D/A	Hsieh Ming	—	8,872,539	view →
2019-10-24	SC	Hsieh Ming	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →